A Clinical Trial of Breast Cancer Neo-adjuvant Therapy Based on Molecular Pathway in FUSCC

  • STATUS
    Recruiting
  • participants needed
    20
  • sponsor
    Fudan University
Updated on 26 January 2022
paclitaxel
carcinoma
metastasis
carboplatin
capecitabine
pertuzumab
EGFR
carcinoma in situ
fulvestrant
herceptin
mammogram
ductal carcinoma

Summary

This is a Phase Ib/II, prospective , open-label, single center, Bayesian adaptive design, umbrella study evaluating the efficacy and safety of neo-adjuvant therapy in patients with breast cancer.

Details
Condition Breast Cancer Diagnosis, Breast Cancer, breast carcinoma, cancer, breast
Treatment A, B, CL1, CL2, CLH1, CLH2, CH1, CH2, CT1
Clinical Study IdentifierNCT04215003
SponsorFudan University
Last Modified on26 January 2022

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note